Essentially, IL-10 acts to dampen anti-tumor immune responses: it inhibits the activation of Th1 responses, reduces cytotoxic T cell and NK cell activity, and upregulates expression of checkpoint molecules on antigen-presenting cells [32]. This evidence concerns the gene IL10 and neoplasm.